Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation: a systematic review and meta-analysis

Published:2012-09 Issue:1017 Volume:85 Page:e694-e701
ISSN:0007-1285
Container-title:The British Journal of Radiology
language:en
Short-container-title:BJR

Author:

Zhu W,Xing L,Yue J,Sun X,Sun X,Zhao H,Yu J

Publisher

British Institute of Radiology

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://www.birpublications.org/doi/pdf/10.1259/bjr/29946900

Reference52 articles.

1. Translating insights from the cancer genome into clinical practice

2. The cancer biomarker problem

3. Enabling personalized cancer medicine through analysis of gene-expression patterns

4. Decreased Expression of Gene Cluster at Chromosome 1q21 Defines Molecular Subgroups of Chemoradiotherapy Response in Esophageal Cancers

5. Gene Expression Profiling of Localized Esophageal Carcinomas: Association With Pathologic Response to Preoperative Chemoradiation

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interim position emission tomography-computed tomography during multimodality treatment of locally advanced esophageal cancer: a scoping review;Quantitative Imaging in Medicine and Surgery;2023-09

2. Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer;Scientific Reports;2023-04-08

3. Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy;Surgery;2022-08

4. Complementary imaging of ultrasound and PET/CT: A new opportunity?;Clinical Hemorheology and Microcirculation;2021-10-06

5. Radiomics in the Setting of Neoadjuvant Radiotherapy: A New Approach for Tailored Treatment;Cancers;2021-07-17